The central doctrine of mycobacterial immunity relies on CD4+ T cell IFN-γ production; however, this measurement fails to differentiate infection from disease, predict those at high risk for progression, or predict vaccine immunogenicity [17, 18]. The gene discussed is IFNG; the disease is infection.